Highlights from the ASP Quarterly Update ASP Skin Substitute Codes added effective April 1, 2024 HCPCS Descriptor Q4184 Cellesta or duo per sq cm Q4168 Amnio band, 1 mg Q4188 Amnio armor 1 sq cm Q4259 Celera per sq cm…
The 2024 JWC Award winners have now been announced! The American Professional Wound Care Association (APWCA) is honored to be the recipient of the Silver Medal in the award category of Cellular, Acellular, and Matrix-like Products (CAMPs). This achievement was made possible thanks…
The American Professional Wound Care Association (APWCA) is pleased to introduce our newest educational offering. Throughout 2024 there will be quarterly webinars sponsored by our generous sponsors each season. Please save the dates to join us for these informative online…
Great News!!! CMS has issued a correction to the 2024 rates for outpatient hyperbaric oxygen therapy, reversing the 41.5% rate cut and increasing reimbursement from the 2023 rates. This would not have been possible without the advocacy of wound care providers, such…
Collective letter to the HSS Secretary Xavier Becerra and CMS Administrator Chiquita Brooks-LaSure As you may be aware, Medicare reimbursement for hyperbaric oxygen (HBO2) therapy will be cut by 41.5% in 2024 if the Centers for Medicare and Medicaid (CMS)…
URGENT: CALL TO ACTION! Comments to CMS must be submitted before December 10th On November 2, 2023, the Centers for Medicare & Medicaid Services (CMS) finalized Medicare payment rates for Hospital Outpatient Prospective Payment System (OPPS) services for calendar year (CY) 2024….
Dr. Jeffrey Niezgoda is a nationally recognized leader in wound care, hyperbaric medicine, limb preservation, and regenerative medicine with more than 30 years of clinical experience. He is the Past President of the American Professional Wound Care Association (APWCA) and the American College of Hyperbaric Medicine.
Dr. Niezgoda has directed advanced wound care and hyperbaric programs, contributed to medical device development and clinical research, and served in leadership roles supporting innovation in wound management technologies and patient care. His expertise includes wound healing, vascular care, hyperbaric medicine, and regenerative clinical services.
Dr. Barbara Delmore is a board-certified wound care nurse, researcher, educator, and Senior Nurse Scientist at NYU Langone Health. With more than 35 years of nursing experience, she specializes in pressure injury prevention, chronic wound management, and evidence-based wound care practices.
Dr. Delmore has authored numerous publications, served on professional advisory boards, and received national recognition for her contributions to wound care research, education, and clinical innovation.
Dr. Jeffrey Lehrman is a nationally recognized expert in wound care documentation, coding, compliance, and podiatric medicine. Through Lehrman Consulting, LLC, he provides education and guidance related to healthcare coding, reimbursement, and regulatory compliance.
Dr. Lehrman serves as a staff liaison at the AMA CPT® Editorial Panel meetings and has held leadership positions within APWCA and other professional organizations focused on wound care and podiatric surgery.
Dr. Mark Melin is a Senior Associate Consultant at the Mayo Clinic specializing in wound care, vascular medicine, and advanced wound healing technologies. His clinical expertise includes vascular assessment, chronic wound management, and emerging technologies in wound care.
Dr. Melin actively contributes to research, education, and advancements in wound healing practices focused on improving patient outcomes and interdisciplinary care.
Dr. Kathya Zinszer is a podiatric physician specializing in diabetic foot care, wound management, limb preservation, and public health advocacy. She currently serves at Geisinger Medical Center and has extensive experience in both clinical practice and wound care education.
Dr. Zinszer has contributed to wound care publications, professional organizations, and clinical guideline initiatives related to diabetic foot management and wound prevention strategies.
Dr. Thomas Serena is an internationally recognized wound care specialist, researcher, educator, and founder of The SerenaGroup®. He has established wound care centers throughout the United States and internationally and has led more than 100 clinical trials focused on wound healing and advanced therapies.
Dr. Serena has authored hundreds of scientific publications, delivered lectures worldwide, and held leadership positions within multiple wound care organizations, including APWCA, the Wound Healing Society, and the American College of Hyperbaric Medicine.
